Document Detail

Elimination of Local Abnormal Ventricular Activities: A New End Point for Substrate Modification in Patients with Scar-Related Ventricular Tachycardia.
MedLine Citation:
PMID:  22492578     Owner:  NLM     Status:  Publisher    
BACKGROUND: Catheter ablation of ventricular tachycardia (VT) is effective and particularly useful in patients with frequent defibrillator interventions. Various substrate modification techniques have been described for unmappable or hemodynamically intolerable VT. Non-inducibility is the most frequently used endpoint but is associated with significant limitations such that the optimal endpoint remains unclear. We hypothesized that elimination of local abnormal ventricular activities (LAVA) during sinus rhythm or ventricular pacing would be a useful and effective endpoint for substrate-based VT ablation. As an adjunct to this strategy, we used a new high density mapping catheter and frequently employed epicardial mapping. METHODS AND RESULTS: Seventy patients (67±11 y, 7 female) with VT and structurally abnormal ventricle(s) were prospectively enrolled. Conventional mapping was performed in sinus rhythm in all while a high density Pentaray(TM) mapping catheter was used in the endocardium (n=35) and epicardially. LAVA were recorded in 67 patients [95.7%, 95% confidence interval (CI; 89.2%, 98.9%)]. Catheter ablation was performed targeting LAVA using an irrigated-tip catheter placed endocardially via a transeptal or retrograde aortic approach or epicardially via the sub-xiphoid approach. LAVA were successfully abolished or dissociated in 47 of 67 patients [70.1%, 95% CI (58.7%, 80.1%)]. In multivariate analysis, LAVA elimination was independently associated with a reduction in recurrent VT or death [hazard ratio 0.49, 95% CI (0.26, 0.95), P=0.035] during long-term follow-up (median 22 months). CONCLUSIONS: LAVA can be identified in most patients with scar-related VT. Elimination of LAVA is feasible and safe and associated with superior survival free from recurrent VT.
Pierre Jaïs; Philippe Maury; Paul Khairy; Frédéric Sacher; Isabelle Nault; Yuki Komatsu; Mélèze Hocini; Andrei Forclaz; Amir S Jadidi; Rukshen Weerasooryia; Ashok Shah; Nicolas Derval; Hubert Cochet; Sébastien Knecht; Shinsuke Miyazaki; Nick Linton; Lena Rivard; Matthew Wright; Steven Wilton; Daniel Scherr; Patrizio Pascale; Laurent Roten; Michala Pedersen; Pierre Bordachar; François Laurent; Steven J Kim; Philippe Ritter; Jacques Clémenty; Michel Haïssaguerre
Related Documents :
24884458 - The relation of location-specific epicardial adipose tissue thickness and obstructive c...
696568 - Blood pressure levels in acute myocardial infarction.
8518058 - Circadian and seasonal factors in the pathogenesis of acute myocardial infarction: the ...
21878048 - Treatment of persistent atrial fibrillation using phased radiofrequency ablation techno...
7614278 - Prospective multicenter evaluation of cocaine-associated chest pain. cocaine associated...
22587748 - Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-4-4
Journal Detail:
Title:  Circulation     Volume:  -     ISSN:  1524-4539     ISO Abbreviation:  -     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-4-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
1 CHU Bordeaux, Bordeaux, France;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A Comparative Review of Petroleum-Based and Bio-Based Acrolein Production.
Next Document:  Ablation for Ventricular Tachycardia during Stable Sinus Rhythm: As Easy as Stopping LAVA?